Medtide Inc. (HKG:3880)
Hong Kong · Delayed Price · Currency is HKD 21.52
+0.80 (3.86%)
Sep 30, 2026, 3:59 PM HKT
Medtide Market Cap
Medtide has a market cap or net worth of 3.05 billion as of October 1, 2026. Its market cap has decreased by -30.85% in one year.
Market Cap
3.05B
Enterprise Value
1.91B
Revenue
635.93M
Ranking
n/a
PE Ratio
15.65
Stock Price
21.52
ChartMarket Cap Chart
Since June 30, 2025, Medtide's market cap has decreased from 4.37B to 3.05B, a decrease of -30.13%. That is a compound annual growth rate of -24.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 3.05B | -29.40% |
| Dec 31, 2025 | 4.32B | -1.04% |
| Jun 30, 2025 | 4.37B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Qyuns Therapeutics | 3.79B |
| Mirxes Holding Company | 3.66B |
| Viva Biotech Holdings | 3.18B |
| BioDlink International Company | 2.86B |
| Laekna | 2.71B |
| Jiangsu Recbio Technology | 2.71B |
| Beijing Luzhu Biotechnology | 2.69B |
| HJ Science | 2.66B |